Supplementary Figure 4 from Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 4. Shows cell killing with combination paclitaxel and RG7787 in vitro
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362622137
